BioSpace News Archive

New Journal of Thoracic Oncology publication concludes prospective application of technology may translate to improved outcomes for non-small cell lung cancer patients

Vizuri Health Sciences LLC, announced that it has been selected to make an oral presentation of findings from a randomized, double blind Phase 2 osteoarthritis knee pain study at the American College of Rheumatology and the Association of Rheumatology Health Professionals’ 2019 Annual Meeting, which will take place from November 8-13 in Atlanta, Georgia.

Modulim is pleased to announce the appointment of Richard Oberreiter as its new Chief Executive Officer Oberreiter succeeds Modulim’s founder, CEO and Chief Technical Officer, David Cuccia, Ph.D., who will now dedicate his efforts in taking the company’s breakthrough platform technology, known as spatial frequency domain imaging, into new areas and applications.

Phase 2a Study Showed Statistically Significant Decreases (p<0.001) in Clinical Biomarkers of Alzheimer’s Disease

The RarePlex Staining Kit family includes Panel Kits and Developer Kits which may be used in combination to create custom assays.

Led by Dr. Virginia Litwin, Vice-President of Flow Cytometry, will include pharmaceutical, biotech and regulatory leaders in biomarker research.

First biologic approved in the European Union for adults with severe chronic rhinosinusitis with nasal polyposis

The Company operates twelve manufacturing locations across both North America and Asia and employs approximately 1,100 people.

Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal”) and Y-Biologics (together the “Companies”) today announced a research collaboration agreement for the discovery and development of novel bispecific antibodies for the treatment of leukemia. Under the terms of the agreement, Y-Biologics will contribute its novel bispecific antibody platform technology, ALiCE, and Pascal will utilize its proprietary antibodies.

Covetrus®, a global leader in animal-health technology and services, announced that it will release third quarter 2019 results the morning of Tuesday, November 12, 2019.